Key Points: In today’s Recommendations for Industry, we discuss a return to normal. Read more below. In a recent paper published in JAMA Neurology, CIDRAP
Key Points: In today’s Recommendations for Industry, we discuss the impact of the national COVID plans on workforce decision-making. Read more below. White House Releases
Key Points: In today’s Recommendations for Industry, we discuss TAG’s weekly COVID matrix and its indicators for endemic vs. pandemic and related masking requirements. Read
Key Points: In today’s Recommendations for Industry, we discuss the question: When can our business reduce or rescind our masking requirements? Read more below. Further
Key Points: In today’s Recommendations for Industry, we discuss the continued decline of COVID and the lessons it continues to impart for infectious disease (and
Key Points: In today’s Recommendations for Industry, we discuss TAG’s matrix and the current trends of COVID and its variants. Read more below. As countries
Key Points: In today’s Recommendations for Industry, we discuss our guarded optimism for the ebbing of Omicron. Read more below. OSHA Withdraws Its Workplace Vaccine
Key Points: In today’s Recommendations for Industry, we discuss Omicron’s path across the US. Read more below. U.S. hospitals have been inundated with Omicron cases;
Key Points: In today’s Recommendations for Industry, we discuss new studies suggesting that flu shots, measles vaccines, and the common cold can cross-protect against COVID.
Key Points: In today’s Recommendations for Industry, we discuss the updated CDC isolation guidelines (coupled with antigen testing) while reflecting on how long this new
